GLP-1 Side Effects: What to Expect
Jillian Foglesong Stabile, MD
Board-certified Family Medicine · Diplomate, ABOM · Reviewed Jun 4, 2026
Most people brace for the wrong week. They expect the hardest day to be the first injection. It usually is not. The queasy stretch tends to land a few days after a dose goes up, then fades as the body settles. Knowing when that happens, and what to do when it does, is most of the battle. This guide walks you through it week by week: what is common, what actually helps, and the clear signals that it is time to call your clinician.
The short answer
Most GLP-1 side effects are gastrointestinal (nausea, constipation, reflux, looser stools) and tend to peak in the first few weeks or after each dose increase, then ease as your body adapts. Small meal changes, steady hydration, and a slow clinician-guided dose schedule handle most of it. A few symptoms, however, mean you call your clinician right away.
What you will learn
- Which side effects are common, and which are rare but serious
- Why the days after a dose increase feel different from the rest
- Practical food, fluid, and timing changes that tend to help
- The specific warning signs that mean “call your clinician now”
- How a good provider sets up your dose so you are not managing this alone
Chapter 01 · The science
Why GLP-1s cause side effects
GLP-1 medications work partly by slowing how fast your stomach empties and by dialing down appetite signals in the brain. That is the same machinery that helps with weight; it is also the reason your gut feels different for a while.
Here is the thing. Your stomach is used to emptying on a schedule. When that slows down, food sits longer, and you feel full faster, sometimes queasy, sometimes backed up. The most common reported effects across both semaglutide and tirzepatide are nausea, vomiting, diarrhea, and constipation, and they show up most in the early weeks.1, 3
~37%
of users reported nausea in real-world pooled data (2026)
most
cases rated mild to moderate; intensity eases as the body adapts
Self-reported community data, 2026. Individual results vary widely.
That word “most” is doing real work, so let us get specific about what the pattern actually looks like.
Are they dangerous?
For most people, the common ones are uncomfortable, not dangerous. They tend to be temporary and tied to dose changes. A small number of effects are serious and rare; those are worth memorizing. Individual results vary, and your own pattern is something your clinician should know about.
Chapter 02 · The timeline
What to expect, week by week
The honest version: there is no universal calendar, but there is a rhythm. Side effects cluster in the first few weeks and again for a few days after each step up in dose. In the registration trials most were mild to moderate and eased over time, most often around dose increases. Between steps, most people feel steadier.5
Both semaglutide and tirzepatide are titrated, meaning your clinician starts you low and increases the dose in stages, generally with at least four weeks at each step, specifically to keep stomach side effects manageable.1, 2
The dose-escalation period is when side effects are highest. Expect the rough days there, not scattered at random.
A rough map of how the pattern tends to unfold:
- Weeks 1 to 4 (starting dose). A low, get-acquainted dose. Some people feel mild nausea or early fullness; many feel very little. The starting dose is deliberately gentle.
- The few days after each dose increase. This is the predictable pinch point. Nausea, and sometimes vomiting or looser stools, tend to tick up for a few days, then calm down as your body adjusts.4
- Steady stretches between increases. Many people feel noticeably better here. Appetite is lower, the queasiness has backed off, and daily life feels normal again.
- Constipation can be the slow burn. Unlike nausea, which spikes and fades, constipation can build quietly over weeks. It is common and usually manageable with fluids, fiber, and movement.3, 4
For most people the worst of the nausea lives in the early weeks and the days right after a dose goes up, then fades as the body adapts. If side effects are not settling, that is a conversation to have with your clinician, who may adjust the pace.
Chapter 03 · What helps
What actually helps the nausea and GI changes
You have more control here than it feels like at 3 p.m. on a queasy Tuesday. None of this is a prescription or a dose instruction; it is the everyday-habits layer that clinicians and dietitians point to most. This content is educational, not medical advice for your situation; a licensed clinician decides your treatment and dose.
Start with food, because that is where most of the relief comes from.
- Eat smaller, more often. A slowed stomach does not love a big plate. Smaller portions, spread out, mean less to sit and churn (dietitian guidance, 2025).
- Go easy on greasy, fried, and very sweet foods. High-fat and heavy meals are the usual triggers when digestion is slow. Blander, lower-fat options tend to sit better.
- Slow down at the table. Set the fork down between bites. Stop at “satisfied,” not “stuffed,” because fullness is arriving earlier than your habits expect.
Now fluids.
- Drink steadily, and cool. Reduced appetite plus any vomiting or loose stools can quietly dehydrate you. Room-temperature or cold drinks are often easier than hot ones when you feel off (dietitian guidance, 2025).
- Ginger and small, simple snacks. Crackers, ginger, mint, an apple. Old-fashioned, and they help a lot of people.
For constipation
More water, more fiber, more walking, in that order of “try this first.” If it is stubborn, your clinician can talk you through options that fit your specific history.
Chapter 04 · Side by side
Common effects and what tends to help
A simple orientation. This table is not medical advice for your situation; your clinician knows your history and the table does not.
| Common effect | When it usually shows up | What tends to help | Talk to your clinician if |
|---|---|---|---|
| Nausea | Early weeks; days after a dose increase | Smaller meals, lower-fat foods, slow eating, ginger, steady fluids | It stops you eating or drinking, or comes with vomiting that will not quit |
| Constipation | Builds gradually over weeks | More water, fiber, daily movement | No relief for several days, or pain and bloating |
| Reflux / heartburn | Variable; often after larger meals | Smaller meals, sitting up after eating, fewer late meals | It is frequent or painful |
| Looser stools / diarrhea | Early weeks; after dose changes | Bland foods, fluids with electrolytes, rest | Severe, persistent, or you cannot stay hydrated |
| Fatigue | Early weeks | Steady eating, hydration, sleep | It is severe or not improving after a few weeks |
Swipe to see the full table on a phone.
Chapter 05 · Warning signs
When to call your clinician
Here is the line that matters: comfort issues you can usually manage at home; pain and the inability to keep fluids down are different, and they mean you reach out. Do not wait these ones out.
Seek prompt medical care, or call your clinician right away, for:
- Severe, unrelenting belly pain, especially upper abdomen pain that bores through to your back, sometimes with vomiting. This is the classic pancreatitis warning pattern and is not the same as everyday queasiness.1, 4
- Pain in the upper-right abdomen, which can point to gallbladder trouble.1
- Vomiting or diarrhea you cannot get ahead of, to the point you cannot keep fluids down or are getting dehydrated.
- Signs of an allergic reaction, like swelling, trouble breathing, or a spreading rash.
Ordinary side effects are uncomfortable and fade. The serious ones are severe, persistent, and often painful. When in doubt, call.
There are also rarer risks worth knowing about: a boxed warning related to a specific type of thyroid tumor seen in animal studies, and the pancreatitis and gallbladder risks above. These are exactly why GLP-1 medications are prescription-only and why a physician reviews your history before prescribing.
A quiet truth about this whole category: where many people run into trouble is not the medication itself but going through the early weeks with no one to reach when something feels off. The standard worth demanding from any GLP-1 provider is simple. You should be able to reach a clinician promptly when a side effect worries you, get help adjusting the pace if you need it, and never feel like you are managing this alone. If a brand cannot tell you exactly how follow-up works before you pay, treat that as a real answer. (This is the part sipra was built around. Here is how that support works.)
Your three-step plan from here
The pattern is knowable. The tools are simple. The serious signals are short enough to memorize.
- Watch the pattern, not the calendar. Expect the rough days to cluster after dose increases, and have your food and fluid plan ready for those few days.
- Use the everyday layer first. Smaller, lower-fat meals, slow eating, steady cool fluids, and movement for constipation cover most of it.
- Know your two lists. Keep the “manage at home” list and the “call now” list where you can see them, and choose a provider that makes a clinician easy to reach.
You do not have to guess your way through the first month.
Lose weight with a plan made just for you
- Same-day doctor visits and prescriptions
- Semaglutide, tirzepatide & other GLP-1s
- FSA & HSA eligible with all plans
From$79/mo
+ Sipra membership*
*Price includes medication only. Active $99/mo Sipra membership required.
Frequently asked questions
Sources
- U.S. Food and Drug Administration. Wegovy (semaglutide) Prescribing Information. Accessed June 2026. accessdata.fda.gov
- U.S. Food and Drug Administration. Zepbound (tirzepatide) Prescribing Information. Accessed June 2026. accessdata.fda.gov
- Cleveland Clinic. "GLP-1 Agonists: What They Are, How They Work & Side Effects." Accessed June 2026. my.clevelandclinic.org
- American Gastroenterological Association. "AGA Clinical Practice Update on Management of Gastrointestinal Side Effects of GLP-1 Receptor Agonists." 2025. gastro.org
- Wilding JPH, et al. "Once-Weekly Semaglutide in Adults with Overweight or Obesity" (STEP 1). New England Journal of Medicine, 2021. nejm.org
Trademark attribution. Ozempic®, Rybelsus®, and Wegovy® are registered trademarks of Novo Nordisk A/S. Zepbound® and Mounjaro® are registered trademarks of Eli Lilly and Company. sipra is not affiliated with or endorsed by these companies.
Medically reviewed by
Jillian Foglesong Stabile, MD, FAAFP, DABOM
Was this helpful?
Keep reading
Weight LossGLP-1 weight loss 101: how semaglutide and tirzepatide actually work
17 min read
Weight LossHow GLP-1 Treatment With sipra Works, Step by Step
16 min read
Weight LossThe Real Cost of GLP-1 Medication: Every Number Before Your Card Is Charged
16 min read
Weight LossBranded vs compounded GLP-1s: the real difference in 2026
9 min read
Weight LossGLP-1 Myths That Won't Die (and the Facts That Beat Them)
9 min read
Weight LossHow GLP-1s work in the body: the science of appetite and satiety
9 min read
Weight LossWhat 503A compounding means (and why your prescription is made for you)
11 min read
Weight LossWho Should Not Take a GLP-1? Contraindications a Physician Screens For
9 min read